Guest guest Posted June 20, 2012 Report Share Posted June 20, 2012 Sorry, this came to me epilepsy therapy project,here is the article; Marker of Inflammation May be Elevated with Certain Seizure Types In recent studies presented in the May issue of the journal Epilepsia, Doctors Alapirtti and colleagues from the department of Neuroscience and Rehabilitation, Tampere University Hospital in Tampere, Finland and the departments of Virology and Neurology at the University of Turku and Clinical Neurophysiology Pirkanmaa Hospital District detailed an analysis looking at a marker of inflammation known as C-reactive protein (CRP) and its relationship to specific seizures. The investigators looked at 31 patients who had drug resistant epilepsy of partial onset who were admitted for a video EEG monitoring unit at the Tampere University Hospital. All of these patients underwent continuous monitoring for four days with the idea of recording seizures as part of their clinical evaluation for potential epilepsy surgery. They drew blood samples at the beginning of the four day recording at various points in the admission and in relationship to their recorded seizures. Their goal? To see whether there was a change in the CRP level after seizures in patients who had refractory epilepsy, and to look at the difference in baseline CRP levels in healthy patients versus those with epilepsy. They also assessed elevated CRP levels and if the CRP levels varied with epilepsy syndrome, cause of epilepsy, length of epilepsy, seizure duration, seizure frequency, and the current use of enzyme inducing antiepileptic drugs. The results? The investigators found that CRP was significantly higher in patients who had refractory partial epilepsy as compared to patients without epilepsy. All five patients with an elevated CRP level had temporal lobe epilepsy versus other epilepsy types. They noted that the most important predictor of an increase in the CRP level was having a secondary generalized tonic-clonic seizure. They concluded that the higher baseline level in patients with epilepsy compared with healthy controls show that CRP concentrations are effected in patients with drug resistant epilepsy. It also suggests that a single generalized tonic-clonic seizure stimulates CRP production. These results emphasize the association between inflammation and drug resistant epilepsy. And what does this mean? This study is important for two reason: 1. It shows there is clearly an elevation of the markers of inflammation in patients with drug resistant epilepsy and; 2. It also shows that single seizures can significantly increase CRP. This finding implies that an approach for the treatment of epilepsy could involve the use of an anti-inflammatory agent. This idea if translated to therapy could change the way we treat seizures. Much more research needs to be done in order to understand the full meaning of this study, but early signs are very positive. by ph I. Sirven, MD Editor-in-Chief, epilepsy.com Last Reviewed: 6/20/2012 Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.